BEAT Heartbeam, Inc.
$0.41▼ -0.97%
Healthcare
Other
After hours
$0.42▲ +3.79%
Sep 11, 7:55 PM ET
Volume 271.6K
Avg Volume (10D) 354.4K
Key Metrics & Fundamentals
Market Cap
$22.90M
P/E Ratio
–
Div Yield
–%
52W Range
0.39 - 4.00
% vs 50 MA
-22.71%
% vs 200 MA
-64.10%
RSI-14
32.8
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.70
Free Cash Flow
-$3.59M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$5.04M
COGS
–
Operating Exp
$5.09M
Operating Income
-$5.09M
EBIT
-$5.09M
Pretax Income
-$5.04M
Net Income
-$5.04M
EPS (Diluted)
-0.10
Price & Volume History
Loading chart…
Recent News
HeartBeam, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
HeartBeam Inc (BEAT) (Q2 2026) Earnings Call Highlights: FDA Submission Advances and Commercial ...
GuruFocus.com · Aug 14, 2026 5:02 AM
HeartBeam Reports Second Quarter 2026 Results
Business Wire · Aug 13, 2026 8:01 PM
HeartBeam Inc (BEAT) Q2 2026 Earnings Report Preview: What To Look For
GuruFocus.com · Aug 12, 2026 1:33 PM
HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time
Business Wire · Jul 30, 2026 11:00 AM
HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device
Business Wire · Jul 14, 2026 11:00 AM
HeartBeam (BEAT) Advances Modern Cardiac Care, Expanding Use of ECG Data Outside of the Hospital
NewMediaWire · Jul 1, 2026 5:40 PM
HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule
Business Wire · Jul 1, 2026 5:05 PM
HeartBeam (BEAT) Completes Enrollment Ahead of Schedule in Heart Attack Detection Pilot Study
NewMediaWire · Jun 30, 2026 7:00 PM
HeartBeam (BEAT) Stock Sees Fair Value Cut As Analysts Weigh Dilution And Slower Ramp
Simply Wall St. · Jun 27, 2026 1:08 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BEAT's money flow as a full page
Social Sentiment
No Reddit posts found for BEAT.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.